Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders
暂无分享,去创建一个
[1] Xiaohui Cui,et al. Protective role of antioxidant supplementation for depression and anxiety: A meta-analysis of randomized clinical trials. , 2022, Journal of affective disorders.
[2] K. Stachowicz,et al. The treatment of depression — searching for new ideas , 2022, Frontiers in Pharmacology.
[3] Jonathan Cueto-Escobedo,et al. Participation of the Serotonergic System and Brain-Derived Neurotrophic Factor in the Antidepressant-like Effect of Flavonoids , 2022, International journal of molecular sciences.
[4] A. Puga-Olguín,et al. Pharmacological, Neurochemical, and Behavioral Mechanisms Underlying the Anxiolytic- and Antidepressant-like Effects of Flavonoid Chrysin , 2022, Molecules.
[5] Xiujuan Zhao,et al. Flavonoids for depression and anxiety: a systematic review and meta-analysis , 2022, Critical reviews in food science and nutrition.
[6] P. Tonin,et al. Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy , 2022, Pharmaceutics.
[7] R. Freire,et al. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options , 2021, Focus.
[8] B. Puri,et al. Polyphenols as adjunctive treatments in psychiatric and neurodegenerative disorders: efficacy, mechanisms of action, and factors influencing inter-individual response. , 2021, Free radical biology & medicine.
[9] P. Tonin,et al. Efficacy of Essential Oils in Pain: A Systematic Review and Meta-Analysis of Preclinical Evidence , 2021, Frontiers in Pharmacology.
[10] Emre Kıcıman,et al. Understanding Side Effects of Antidepressants: Large-scale Longitudinal Study on Social Media Data , 2021, JMIR mental health.
[11] J. Amsterdam,et al. Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les médicaments à base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une méta-revue des méta-analyses d’essais randomisés co , 2021, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[12] R. Freire,et al. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options , 2020, Frontiers in Psychiatry.
[13] Jonathan Cueto-Escobedo,et al. Chrysin reduces anxiety-like behavior through actions on GABAA receptors during metestrus-diestrus in the rat , 2020, Behavioural Brain Research.
[14] P. Kris-Etherton,et al. Nutrition and behavioral health disorders: depression and anxiety. , 2020, Nutrition reviews.
[15] P. Tonin,et al. Pattern of triptans use: a retrospective prescription study in Calabria, Italy , 2020, Neural regeneration research.
[16] H. Whiteford,et al. New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis , 2019, The Lancet.
[17] P. Masand,et al. Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review , 2018, Chonnam medical journal.
[18] C. García-Viguera,et al. Aqueous Extract of Pomegranate Alone or in Combination with Citalopram Produces Antidepressant-Like Effects in an Animal Model of Menopause: Participation of Estrogen Receptors , 2017, International journal of molecular sciences.
[19] L. Howard,et al. Antidepressant Treatment for Postnatal Depression , 2017, Issues in mental health nursing.
[20] A. Steinmetz,et al. Conservation and sustainable use of medicinal plants: problems, progress, and prospects , 2016, Chinese Medicine.
[21] A. Graziottin,et al. Depression and the menopause: why antidepressants are not enough? , 2009, Menopause international.
[22] A. Hamilton,et al. Medicinal plants, conservation and livelihoods , 2004, Biodiversity & Conservation.
[23] C. M. Contreras,et al. A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts. , 2003, Phytomedicine : international journal of phytotherapy and phytopharmacology.